Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TRAVATAN Z
- Interval Intraocular Pressure in Intravitreal Injection Study
- Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®
- Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
- Stop Retinal Ganglion Cell Dysfunction Study
- 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular Hypertension
- Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
- Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
- Effect of SIMBRINZA® Suspension as an Added Therapy to a Prostaglandin Analogue
- Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®
- An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension
- Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
- An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
- Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction
- Efficacy of Changing to TRAVATAN® From Prior Therapy
- Efficacy of Changing to TRAVATAN® From Prior Therapy
- A Multicenter Study of the Pigmentation in the Trabecular Meshwork After Two Years of Treatment With TRAVATAN 0.004% Ophthalmic Solution
- AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
- Assessment of Intraocular Pressure (IOP) Control in Subjects With Open-Angle Glaucoma or Ocular Hypertension Treated With Travoprost 0.004% (TRAVATAN® Z) or Bimatoprost 0.01% (LUMIGAN®)
- Travoprost 3-Month Safety and Efficacy Study
- Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%
- Effects of Latanoprost, Bimatoprost and Travoprost in Patients With Latanoprost-resistant Glaucoma
- Effects of Anti-Glaucoma Medications on the Ocular Surface
- Divided Dose of TRAVATAN®
- Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface Disease
- Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Efficacy and Safety of Travoprost 0.004% Versus Tafluprost 0.0015% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension
- Efficacy Study of Travoprost APS Versus TRAVATAN
- Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US
- Exploratory Study Comparing Signs and Symptoms in Patients With Ocular Hypertension or Glaucoma Using Xalatan R® or Travatan Z®
- Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN
- How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?
- Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT
- Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
- Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
- Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)
- Effects of Travatan Z and Xalatan on Ocular Surface Health
- The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye
- Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost
- A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension
- IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
- Short Term Comparative Study of Xalatan With Benzalkonium Chloride vs. Travatan Z Without Benzalkonium Chloride in Healthy Volunteers
- A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
- Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
- Influence of Prostaglandins on Ocular Blood Flow in Glaucoma Patients
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
- Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan
- Mechanism of Action of TRAVATAN 0.004% in Subjects With Glaucoma or Ocular Hypertension
- A Long-term Safety Study of Once-daily Travatan
- A 6-Week Safety and Efficacy Study of Travatan Compared to Xalcom in Subjects With Open-Angle Glaucoma(OAG) or Ocular Hypertension(OHT)
- Study of TRAVATAN in Subjects With Iris Pigmentation Changes
Clinical trials list
click for details